Sarasota Memorial Hospital is an 897-bed public, nonprofit health system founded in 1925 and governed by a publicly elected hospital board to ensure community-focused, high-quality care. Anchored by its flagship Sarasota campus, the system has grown into multiple hospitals, specialized institutes and a broad network of outpatient, urgent care and emergency facilities serving nearly 2 million patient visits annually. In response to rapid regional growth and community need, the system has doubled the size of its Venice campus, is expanding its nationally recognized Brian D. Jellison Cancer Institute, and is developing a third acute-care hospital in North Port scheduled to open in 2028. The system is also investing heavily in innovation, including a $160 million Epic EHR transformation and advanced clinical technologies such as AI-driven surgical planning, Apple Vision Pro-assisted procedures, and minimally invasive cardiac and urologic therapies. System physicians are national leaders in cardiovascular care, earning global recognition for their “WATCHMAN” program, advanced valve repair techniques and early lung cancer detection that doubles national early-stage diagnosis rates. With more than 140 active clinical research studies, the system brings cutting-edge treatments and trials to local patients, including novel therapies for hard-to-treat cancers. The hospital has earned Medicare’s highest 5-star quality rating for 10 straight years and was recognized with The Leapfrog Group’s “Straight A” designation.
